These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16756)

  • 1. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
    Persson SA
    Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of morphine on the accumulation of DOPA after decarboxylase inhibition in the rat.
    Persson SA
    Eur J Pharmacol; 1979 Apr; 55(2):121-8. PubMed ID: 456411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of LSD and 2-bromo LSD on the DOPA accumulation after central and peripheral decarboxylase inhibition.
    Hollunger G; Persson SA
    Eur J Pharmacol; 1975 Mar; 31(1):156-8. PubMed ID: 1126375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of lysergic and diethylamide (LSD) and 2-bromolysergic acid diethylamide (BOL) on the striatal DOPA accumulation: influence of central 5-hydroxytryptaminergic pathways.
    Persson SA; Johansson H
    Brain Res; 1978 Mar; 142(3):505-13. PubMed ID: 25117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.
    Persson SA
    Psychopharmacology (Berl); 1978 Oct; 59(2):113-6. PubMed ID: 31650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact.
    Spampinato U; Esposito E; Samanin R
    J Neurochem; 1985 Sep; 45(3):980-2. PubMed ID: 3928812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A; Kehr W; Lindqvist M
    J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between spiperone binding, behavioural changes, and in vivo tyrosine hydroxylation in the rat striatum.
    Mjörndal T; Persson SA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):136-9. PubMed ID: 6408490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY; Garcia-Espana A; Lee KY; Carr KD; Goldstein M; Haycock JW; Meller E
    Mol Pharmacol; 1999 Feb; 55(2):202-9. PubMed ID: 9927609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
    Doherty JD; Simonovic M; So R; Meltzer HY
    Eur J Pharmacol; 1980 Jul; 65(2-3):139-49. PubMed ID: 7398783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term application of haloperidol: effects on dopamine and acetylcholine receptors.
    Stock G; Kummer P
    Int Pharmacopsychiatry; 1981; 16(3):144-53. PubMed ID: 6797983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Feb; 234(1):177-81. PubMed ID: 6800566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of the gamma-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration.
    Liljequist S; Engel J
    J Neural Transm; 1979; 46(3):195-204. PubMed ID: 528994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.